Aytu BioPharma, Inc. (AYTU) NASDAQ

2.27

+0.02(+0.89%)

Updated at September 08 04:00PM

Currency In USD

Valuation

Market Cap15.78M
Enterprise Value12.2M
P/E Ratio8.5
PEG Ratio0.08
Price/Sales Ratio0.2
Price/Book Ratio0.4
Enterprise/Revenue0.25
Enterprise/EBITDA2.55

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.02
Operating Margin-0.06

Management Effectiveness

Return On Assets0.01
Return On Equity0.05

Income Statement

Revenue81M
Revenue/Share11.28
Gross Profit49.37M
EBITDA-1.01M
Net Income-15.84M
Diluted EPS-2.86

Balance Sheet

Total Cash18.17M
Total Cash/Share2.96
Total Debt21.42M
Total Debt/Equity0.61
Current Ratio1.03
Book Value Per Share5.69

Price History

52-Week Change-6.58
52-Week High2.85
52-Week Low0.95
Moving Average 50 Days2.34
Moving Average 200 Days1.71

Statistics

Average Volume155,427
Shares Outstanding6.17M
% Held by Institutions55.68

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJanuary 06, 2023